Nvidia, Eli Lilly plan AI drug innovation lab
Digest more
On September 27, 2011, Chief Judge Randall R. Rader of the United States Court of Appeals for the Federal Circuit introduced a Model Order on E-Discovery in Patent Cases at the Eastern District of Texas Judicial Conference. While the proposed Model Order ...
This is the final episode in our three-part GENcast series, where we discuss the virtues of mechanistic modeling and how it can significantly impact critical decision-making points in the drug discovery process, especially as drug developers move closer ...
Innovative Science in the Areas of Small Molecule Modeling, Fragment-Based Design, Transmembrane Proteins, and Antibody Modeling Sets New Standard for Life Science Research and Development SAN DIEGO, CA, Jun 29, 2009 (MARKETWIRE via COMTEX) -- Accelrys ...
Explore the impact of drug discovery automation in 2026, addressing complexity and improving decision-making across laboratories.
The drug discovery and development process can be an arduous endeavor. Manufacturers spend considerable resources and money chasing down potential candidate molecules to create a potential new therapeutic—often resulting in abandoning the candidate in ...
The field of pharmacophore modeling has steadily emerged as a cornerstone in the rational design of kinase inhibitors. By abstracting the essential molecular features required for optimal binding to kinase active sites, researchers are now able to ...
Feedback